NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Background: The relationship between nicotine exposure and Parkinson’s disease (PD) remains controversial. Experimental studies, particularly preclinical trials in animal models, suggest that nicotine may exert neuroprotective effects; however, this has not been adequately addressed in randomized controlled trials (RCTs) involving humans. Methods: Comprehensive searches of PubMed, Web of Science, Scopus, and Google Scholar identified 1,363 studies, of which 13 met the inclusion criteria. Random-effects meta-analysis was conducted using RevMan 5.4 and R 4.1.1. Heterogeneity was assessed using the I² statistic, publication bias using funnel plots and Egger’s test, and study quality using SYRCLE and ToxRTool criteria. The review followed PRISMA guidelines and was registered in PROSPERO (CRD420250633808). Results: Nicotine significantly reduced apoptosis (RR, 0.49; 95% CI, 0.34–0.71), oxidative stress (RR, 0.55; 95% CI, 0.41–0.73), and neuroinflammation (RR, 0.62; 95% CI, 0.49–0.79), while enhancing dopaminergic neuron survival (RR, 1.67; 95% CI, 1.35–2.06), mitochondrial function (RR, 1.55; 95% CI, 1.12–2.14), synaptic protein expression (RR, 1.52; 95% CI, 1.14–2.04), and dendritic spine density (RR, 1.47; 95% CI, 1.19–1.83). The only human randomized trial showed no clinical benefit (RR, 1.00; 95% CI, 0.84–1.49). Subgroup and meta-regression analyses identified study design, dose, duration, and model type as sources of heterogeneity. Our findings suggest that although nicotine shows preclinical promise, clinical efficacy remains unproven. Conclusion: Experimental evidence suggests that nicotine exposure confers neuroprotection against PD, however, clinical efficacy remains unproven, underscoring the need for large-scale mechanistic and translational studies to establish causal relationships in humans.
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.